Login / Signup

Editorial: vedolizumab in inflammatory bowel diseases-less is more? Authors' reply.

Silvio DaneseKavitha SubramaniamJan Van ZylShashi Adsul
Published in: Alimentary pharmacology & therapeutics (2021)
Keyphrases
  • ulcerative colitis
  • patients with inflammatory bowel disease